Article Details

Samsung Bioepis' Ustekinumab Biosimilar Demonstrates PK Equivalence in Healthy Adults

Retrieved on: 2024-07-06 11:09:33

Tags for this article:

Click the tags to see associated articles and topics

Samsung Bioepis' Ustekinumab Biosimilar Demonstrates PK Equivalence in Healthy Adults. View article details on hiswai:

Excerpt

Ustekinumab is a monoclonal antibody targeting the p40 subunit of interleukin (IL)-12 and IL-23, cytokines involved in the pathogenesis of several ...

Article found on: www.centerforbiosimilars.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up